4//SEC Filing
Hoeiland Jesper 4
Accession 0001209191-21-039744
CIK 0001367920other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 8:40 AM ET
Size
12.0 KB
Accession
0001209191-21-039744
Insider Transaction Report
Form 4
Hoiland Jesper
Director
Transactions
- Award
Common Stock
2021-06-10+5,125→ 5,125 total - Award
Stock Option (right to buy)
2021-06-10+10,250→ 10,250 totalExercise: $4.26Exp: 2031-06-09→ Common Stock (10,250 underlying)
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
- [F2]Not applicable.
- [F3]The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022).
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001711694
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 8:40 AM ET
- Size
- 12.0 KB